Jerzak M - Search Results

1

Retrospective comparison between the Prolift and Elevate anterior vaginal mesh procedures: 18-month clinical outcome.

Rogowski A, Bienkowski P, Tarwacki D, Szafarowska M, Samochowiec J, Sienkiewicz-Jarosz H, Jerzak M, Baranowski W. Rogowski A, et al. Among authors: jerzak m. Int Urogynecol J. 2015 Dec;26(12):1815-20. doi: 10.1007/s00192-015-2772-z. Epub 2015 Jul 4. Int Urogynecol J. 2015. PMID: 26142350

2

Reliability and clinical validity of a Polish version of the CONTILIFE: a quality of life questionnaire for urinary incontinence.

Rogowski A, Bienkowski P, Samochowiec J, Mierzejewski P, Jerzak M, Baranowski W. Rogowski A, et al. Among authors: jerzak m. Int Urogynecol J. 2010 Jun;21(6):731-6. doi: 10.1007/s00192-009-1095-3. Epub 2010 Feb 10. Int Urogynecol J. 2010. PMID: 20146056

3

Mesh retraction correlates with vaginal pain and overactive bladder symptoms after anterior vaginal mesh repair.

Rogowski A, Bienkowski P, Tosiak A, Jerzak M, Mierzejewski P, Baranowski W. Rogowski A, et al. Among authors: jerzak m. Int Urogynecol J. 2013 Dec;24(12):2087-92. doi: 10.1007/s00192-013-2131-x. Epub 2013 Jun 8. Int Urogynecol J. 2013. PMID: 23749240

4

Association between metabolic syndrome and pelvic organ prolapse severity.

Rogowski A, Bienkowski P, Tarwacki D, Dziech E, Samochowiec J, Jerzak M, Baranowski W. Rogowski A, et al. Among authors: jerzak m. Int Urogynecol J. 2015 Apr;26(4):563-8. doi: 10.1007/s00192-014-2468-9. Epub 2014 Jul 22. Int Urogynecol J. 2015. PMID: 25047898 Free PMC article.

5

Methylenotetrahydrololate reductase A1298C and C677T polymorphisms and adverse pregnancy outcome in women with PCOS.

Szafarowska M, Segiet A, Jerzak MM. Szafarowska M, et al. Among authors: jerzak mm. Neuro Endocrinol Lett. 2016;37(2):141-6. Neuro Endocrinol Lett. 2016. PMID: 27179578

6

Anti-Müllerian hormone concentration as a biomarker of pregnancy success or failure.

Szafarowska M, Molinska-Glura M, Jerzak MM. Szafarowska M, et al. Among authors: jerzak mm. Neuro Endocrinol Lett. 2014;35(4):322-6. Neuro Endocrinol Lett. 2014. PMID: 25038595

7

Preliminary Results for Personalized Therapy in Pregnant Women with Polycystic Ovary Syndrome During the COVID-19 Pandemic.

Jerzak M, Szafarowska M. Jerzak M, et al. Arch Immunol Ther Exp (Warsz). 2022 Mar 24;70(1):13. doi: 10.1007/s00005-022-00650-z. Arch Immunol Ther Exp (Warsz). 2022. PMID: 35325391 Free PMC article.

8

Successful pregnancy after Intralipid addition to sildenafil and enoxaparin in woman with history of recurrent pregnancy loss (RPL).

Jerzak M, Szafarowska M, Kniotek M, Gorski A. Jerzak M, et al. Neuro Endocrinol Lett. 2016 Dec;37(7):473-477. Neuro Endocrinol Lett. 2016. PMID: 28326740

9

Etanercept immunotherapy in women with a history of recurrent reproductive failure.

Jerzak M, Ohams M, Górski A, Baranowski W. Jerzak M, et al. Ginekol Pol. 2012 Apr;83(4):260-4. Ginekol Pol. 2012. PMID: 22712257

10

Anti-Müllerian hormone level is associated with vitamin D receptor polymorphisms in women with polycystic ovary syndrome.

Szafarowska M, Dziech E, Kaleta B, Kniotek M, Rogowski A, Segiet-Święcicka A, Jerzak M. Szafarowska M, et al. Among authors: jerzak m. J Assist Reprod Genet. 2019 Jun;36(6):1281-1289. doi: 10.1007/s10815-019-01472-3. Epub 2019 May 14. J Assist Reprod Genet. 2019. PMID: 31089932 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters